Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Oct 19, 2026.

Endocrine Crosstalk Between Skeletal Muscle and the Brain

Julien Delezie, Christoph Handschin

Frontiers in Neurology · 2018 · Review

doi:10.3389/fneur.2018.00698

Abstract

Skeletal muscle is an essential regulator of energy homeostasis and a potent coordinator of exercise-induced adaptations in other organs including the liver, fat or the brain. Skeletal muscle-initiated crosstalk with other tissues is accomplished though the secretion of myokines, protein hormones which can exert autocrine, paracrine and long-distance endocrine effects. In addition, the enhanced release or uptake of metabolites from and into contracting muscle cells, respectively, likewise can act as a powerful mediator of tissue interactions, in particular in regard to the central nervous system. The present review will discuss the current stage of knowledge regarding how exercise and the muscle secretome improve a broad range of brain functions related to vascularization, neuroplasticity, memory, sleep and mood. Even though the molecular and cellular mechanisms underlying the communication between muscle and brain is still poorly understood, physical activity represents one of the most effective strategies to reduce the prevalence and incidence of depression, cognitive, metabolic or degenerative neuronal disorders, and thus warrants further study.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 19, 2026. Paragraph numbers are ours, so an answer can point at one.

Exercise is powerful medicine

Physicians increasingly encourage patients to exercise through medical prescriptions of specific physical activity programs based on the strong epidemiological link between a sedentary life style and various diseases. The deleterious effects of physical inactivity often are further exacerbated by excessive calorie intake resulting in obesity. Nevertheless, a sedentary life-style is a strong and independent risk factor for a range of medical conditions such as cardiovascular pathologies, diabetes, certain types of cancer, depression, neurological disorders or stroke, for which the prevalence can be significantly reduced by being active and fit. However even though the epidemiological evidence is strong, our knowledge of the molecular and cellular mechanisms by which exercise promotes health is still rudimentary.

The science of exercise

In terms of weight, skeletal muscle is the most abundant organ of the human body. Its function encompasses the maintenance of postural support, the generation of force and power during voluntary movements, breathing and thermoregulation. In addition, skeletal muscle accounts for a large portion of oxidative metabolism and of insulin-stimulated glucose uptake. Moreover, as a major storage site for glucose, lipids and amino acids, muscle is an essential coordinator of whole-body energy metabolism. For example, muscle protein metabolism rapidly adapts in response to physical exercise, dietary protein or anabolic hormones such as insulin-like growth factor 1 or testosterone. The plasticity of skeletal muscle is further illustrated by the myriad of effects that either endurance- or resistance-based training induce at the cellular and molecular levels. Recent observations in rodents and humans have demonstrated the ability of contracting myofibers to produce and release cytokines and other peptides, so-called myokines, which play a crucial role in the skeletal muscle crosstalk with other tissues and, together with muscle-controlled synthesis and degradation of metabolites, represent an essential mechanism to control whole-body homeostasis.

Exercise response and the involvement of muscle PGC-1α

Exercise rapidly triggers substantial changes at the organismal level depending on various factors, including type, duration and intensity. To optimize contractions, the activity of the cardiovascular, respiratory, metabolic and neuroendocrine systems is modulated. At least in part, these adaptations are initiated from muscle tissue, for example by the paracrine release of nitric oxide (NO), ATP or reactive oxygen species (ROS) by myofibers. Other changes are mediated by hormonal signaling, e.g., by glucagon, catecholamines or growth hormones. For example, hepatic gluconeogenesis and lipolysis in adipose tissue are stimulated to ensure adequate energy supply to contracting myofibers.

In response to exercise, glycolysis products (i.e., lactate, pyruvate), lipolysis products (i.e., glycerol), amino acids (i.e., alanine and glutamine) and ketone bodies (in particular β-hydroxybutyrate; BOHB) are found at higher levels in the circulation. Some of these metabolites, for example lactate and BOHB, are energy substrates for the central nervous system in the context of limited glucose. BOHB and lactate transport is mediated by monocarboxylate transporters (MCTs) at the blood-brain barrier. Interestingly, exercise has been associated with changes in the expression of such transporters (MCT1, 2 and 4) in the rat cortex and hippocampus. Notably, lactate and BOHB are not only metabolic fuels for neuronal cells, but also bind the hydroxycarboxylic acid receptors (HCARs) and behave as signaling molecules at the central level. For instance, lactate influences neuronal activity, calcium signaling, axonal myelination, angiogenesis and memory formation. The most abundant free amino acid in the human body, glutamine, essential as metabolic fuel and a protein building block, is a potent regulator of multiple signaling pathways related to inflammation, cell integrity and metabolism. Interestingly, an elevation of glutamine in the rat hippocampus, striatum, and cerebellum following endurance exercise has recently been demonstrated. However, since the brain is autonomous for the production of glutamine and the blood-brain barrier rather impermeable to this amino acid, a redistribution from skeletal muscle in this context is rather unlikely. Lastly, it is important to highlight the metabolic coupling between neuronal and glial cells. In particular, prolonged exercise diminishes brain glycogen essentially stored in astrocytes providing lactate to adjacent neurons. This lactate shuttle from astrocytes to neurons has been implicated in long-term memory formation, and has been shown to influence endurance capacity.

Exercise-induced cellular stress (e.g., ATP and O2 depletion, Ca2+ elevation, changes in the NADH/NAD+ ratio and mechanical stress) leads to the activation of multiple signaling pathways in skeletal muscle. Therefore, exercise is not only a potent modifier of the metabolome as previously discussed, but also affects the muscle epigenome, transcriptome and proteome. A marked acute exercise-induced hypomethylation of the promoters of the peroxisome-proliferator activated receptor γ coactivator 1α (PGC-1α) and the peroxisome-proliferator activated receptor δ (PPARβ/δ) in human muscle parallels an upregulation of PGC-1α mRNA and protein stability, in part via PPARδ-dependent mechanisms. This PGC-1α-PPARδ axis plays a pivotal role in the regulation of muscle mitochondrial metabolism in the initial phase of exercise, and mediates the increase in mitochondrial biogenesis essential for endurance training adaptation. Importantly, PGC-1α acts as a central regulator of mitochondrial dynamics by recruiting and co-regulating multiple transcription factors including the nuclear respiratory factors NRF-1 and NRF-2, PPARα and PPARδ, and the estrogen-related receptor α (ERRα). The PGC-1α-ERRα association is essential to coordinate lactate homeostasis during muscle contraction and mediates exercise-induced angiogenesis through the induction of VEGF. The active coordination of muscle angiogenesis by PGC-1α is further illustrated by its ability to induce the release of the secreted phosphoprotein 1 (SPP1), which recruits macrophages to help orchestrate multicellular angiogenesis. PGC-1α can also promote remodeling at the neuromuscular junction, which may be mediated by the secretion of neurturin. Overall, PGC-1α integrates various cell signals during exercise.

The exercise-induced perturbations in the muscle milieu also lead to the activation of upstream kinases e.g., AMP-activated protein kinase (AMPK) and deacetylases e.g., SIRT1, that functionally interact with PGC-1α. AMPK is a conserved energy sensor that is present in all mammalian cells, specifically activated in conditions that elevate the AMP:ATP ratio, with exercise being one of the most powerful activators of AMPK especially in human muscles. Acute exercise induces AMPK phosphorylation and enzymatic activity in an intensity-dependent manner, which in turn stimulates ATP production by promoting glucose transport and fatty-acid oxidation. Noteworthy, peripheral administration of the AMPK agonist AICAR can enhance running endurance capacity in sedentary mice. Likewise, a PPARδ agonist (GW501516) induces a gene program in skeletal muscle related to oxidative metabolism similar to endurance exercise. Whether these and related compounds are real “exercise mimetics” remains debatable. Intriguingly, treatment of wild-type mice with AICAR, and to a lesser extent with GW501516, enhances spatial memory and elevates neurogenesis in the hippocampal dentate gyrus area, again similar to exercise. Surprisingly, the effect of AICAR on memory function and hippocampal plasticity is dependent on the expression of the AMPK α2-subunit in muscle cells, providing evidence for a muscle-mediated mechanism.

The wheel of health: neurotrophic and growth factors

In humans, the neurobiological effects of exercise are numerous e.g., reduction of anxiety and depression, improvement of social skills and self-esteem as well as mood and cognitive abilities, in concert with significant structural changes at the central level. Voluntary exercise in a running wheel promotes neurogenesis and long-term potentiation in the adult rodent dentate gyrus. Transcriptomic studies have described changes in gene categories related to chromatin remodeling, neuronal signaling and plasticity, protein synthesis and trafficking, and the inflammatory/immune response in rodent hippocampus after running [reviewed in].

Importantly, one hallmark of physical activity is the central and peripheral induction of the brain-derived neurotrophic factor (BDNF). BDNF is a secretory growth factor belonging to the family of neurotrophins, which supports neural survival, growth, and synaptic plasticity. BDNF can signal via both TrkB and p75NTR receptors and is induced in the hippocampus of exercised rats. Inhibition of the action of BDNF in the central nervous system results in a reduction of the recruitment of the cAMP response-element-binding protein (CREB) to target sites on genes that mediate the exercise-induced enhancement in learning and memory. Moreover, there is evidence that physical activity in humans also elevates the level of circulating BDNF. Similarly, BDNF brain and blood levels also correlate in other species i.e., pigs, rats, and humans. Notably, besides the brain as a potential source, a substantial amount of circulating BDNF originates from megakaryocytes, precursors of blood platelets; hence, the variations in BDNF in exercise studies could be caused by the different activation level of human platelets. The contribution of platelets to the exercise effects, in particular on the brain, remains unexplored, even though BDNF could be transported in platelet-derived vesicles to the brain. Unlike human megakaryocytes, this cell population is not involved in BDNF synthesis in the mouse. In contrast, BDNF is produced and secreted by human and rodent skeletal muscles and is regulated by exercise. Muscle BDNF seems mostly involved in autocrine and paracrine signaling to promote muscle fiber fat oxidation and potentially muscle development, as well as in the retrograde signaling on motor neurons located in the spinal cord. Whether muscle-derived BDNF also signals to the brain, e.g., via TrkB signaling at the blood-brain barrier, remains to be investigated.

The blood-brain barrier consists of endothelial cells, vascular smooth cells, pericytes, basement membranes and astrocytic feet along cerebral microvessels, regulating the exchange between blood and neural tissue. This neurovascular interface acts as a barrier, limiting or facilitating the entry of specific nutrients, metabolites and hormones. For example, the hormone insulin-like growth factor-1 (IGF-1), mainly produced by the liver, can cross the blood-brain barrier and act as a mediator of the exercise-induced changes in hippocampal neurogenesis and BDNF expression. Importantly, the formation and maintenance of dendritic spines in hippocampal neurons in basal conditions depend on the BDNF-dependent induction of PGC-1α after exercise. In neuronal tissue, PGC-1α is a potent suppressor of ROS and thus exerts neuroprotective effects. Interestingly, long-term voluntary running exercise can slow down the progression of some neurodegenerative or age-related central deteriorations in mice. This is consistent with data emerging from human studies, in which aerobic exercise moderately prevents or delays the onset of aging- and neurodegeneration-associated memory loss. Noteworthy, neurogenesis in rodents occurs within an angiogenic niche and exercise-induced vascularization is mediated in part by circulating vascular endothelial growth factor [VEGF;]. Moreover, peripheral blockade of VEGF abolishes running-induced neurogenesis. Importantly, other neurotrophic factors are regulated by physical exercise in rodents. For instance, the expression of the glial cell line-derived neurotrophic factor or neurotrophin-3 is affected by physical exercise in skeletal muscle, the spinal cord, or the brain. These results thus suggest that molecules other than BDNF could also mediate the neuroprotective effects of physical exercise at the central level [discussed in].

Altogether, a combination of blood-born factors and centrally-expressed genes is required to promote angiogenesis and neurogenesis at the central level. Future studies are needed to characterize how IGF-1, VEGF and, putatively, BDNF signaling is integrated by neurons, and how exercise impacts the endothelial and glial cell populations at the blood-brain interface.

From skeletal muscle to the brain: involvement of myokines and metabolites

Since the discovery of interleukin-6 (IL-6) as a cytokine produced by and released from skeletal muscle, various other exercise-induced factors have been identified by biochemical, proteomic, or transcriptomic approaches. These factors, called myokines, have autocrine, paracrine and/or endocrine effects [for review, see]. Importantly, the muscle secretome is not limited to protein hormones, as muscle cells also release or remove circulating metabolites. For instance, forced overexpression of PGC-1α in myocytes triggers the production and release of β-aminoisobutyric acid (BAIBA), which modulates both liver and fat metabolism. In this review, we focus on the recently described mediators of the muscle-to-brain communication (Table 1).

Irisin

In 2002, two studies reported the discovery of a cDNA encoding a novel protein, PeP/Frcp2, now named FNDC5. The secreted form of FNDC5, irisin, is a PGC-1α-dependent myokine induced by exercise. Noteworthy, irisin circulates at levels close to essential metabolic hormones (e.g., insulin, leptin) in humans, and acts on subcutaneous fat, promoting the beigeing and thermogenic program of white adipocytes, thereby increasing energy expenditure. Moreover, irisin has the potential to modulate muscle and liver cell metabolism in vitro [reviewed in]. Interestingly, FNDC5 has been detected in different areas of the brain and has been associated with neural differentiation. Additional evidence implies that FNDC5/irisin is also a part of the transcriptional response to exercise in the mouse hippocampus along with PGC-1α and BDNF. Mechanistically, the study demonstrated that the PGC-1α-dependent induction of FNDC5 in both primary cortical and hippocampal neurons involves the transcription factor ERRα. Moreover, FNDC5 is required to induce BDNF in a cell-autonomous manner, and recombinant BDNF treatment decreased FNDC5 expression as a part of a negative feedback loop. Most strikingly, the elevation of circulating levels of irisin by adenoviral overexpression of FNDC5 in the liver increased BDNF expression in the mouse hippocampus, but not in the forebrain.

Collectively, these data reveal a cellular mechanism by which endurance exercise promotes hippocampal gene expression such as BDNF and PGC-1α related to neuroprotection and memory. While it is unclear whether peripheral or central irisin mediate these effects in the brain, the adenoviral overexpression raises the possibility that circulating irisin could cross the blood-brain barrier, or act on receptors expressed by endothelial cells, to further amplify the effect of exercise on the central nervous system. In that regard, the deletion of FNDC5 in brain or skeletal muscle cells, together with the identification of its receptor, may delineate the exact contribution of systemic vs. local/central irisin. This seems especially important as modulation of central vs. peripheral irisin levels differently affects blood pressure in rodents.

Cathepsin B

The cysteine protease cathepsin B (CTSB) is ubiquitously expressed throughout the body, including human muscle cells during exercise. In the search of muscle-produced factors using a mass spectrometry-based approach, Moon et al. exposed rat myotubes to the AMPK agonist AICAR and identified CTSB as a putative myokine. The authors further demonstrated that short-term AICAR treatment was effective in inducing Ctsb mRNA in myotubes. Moreover, 30 days of wheel-running activity upregulated Ctsb mRNA in the hippocampus and the gastrocnemius muscle (but not in other organs e.g., liver or adipose tissue), as well as plasma levels of CTSB in mice. Likewise, 4 months of treadmill exercise led to a significant increase of plasma CTSB concentrations in rhesus monkeys and humans. Furthermore, Moon et al. showed that CTSB has the property to cross the blood-brain barrier and the application of exogenous CTSB to hippocampal progenitor cells induced both BDNF and doublecortin (DCX) transcripts. Strikingly, physical activity did not promote hippocampal neurogenesis or improved spatial memory in whole-body CTSB KO mice, suggesting that central and/or muscle-derived CTSB could mediate the beneficial effects of physical activity on memory function in rodents. Whether a correlation between human plasma CTSB levels and fitness or memory scores exists, as suggested by the authors, remains to be confirmed. Likewise, it is not clear if a therapeutic elevation of blood CTSB levels would be sufficient to enhance hippocampal-dependent memory function, especially in the aging context. Besides, the physiological effects of chronic exogenous CTSB administration have to be addressed, in particular in light of its involvement in inflammation, cell apoptosis, tumor development and progression. Lastly, the signaling pathway by which peripheral and/or central CTSB promotes BDNF elevation and neurogenesis is still unknown.

L-lactate

A recent study has uncovered a cellular mechanism by which blood-born lactate from contracting muscles signals to the brain to promote angiogenesis. Morland et al. investigated the putative role the hydroxycarboxylic acid receptor 1 (HCAR1), enriched at the blood-brain barrier, as a mediator of lactate-induced central vascularization. They observed that after 7 weeks of wheel-running activity, mice lacking HCAR1 did not show increased VEGFA expression and capillary density in the dentate gyrus or the sensorimotor cortex. Similarly, chronic subcutaneous injections of sodium L-lactate failed to enhance VEGFA expression and vascularization in HCAR1 KO animals, indicating that HCAR1 is essential to mediate the effects of exercise on angiogenesis in specific brain areas. Moreover, in line with the involvement of the phosphatidylinositol 3-kinase/Akt (PI3K/Akt) and extracellular signal-regulated kinase (ERK1/2) signaling pathways in mediating the induction of VEGF, both lactate and a selective HCAR1 agonist failed to activate ERK1/2 and Akt in hippocampal slices lacking HCAR1. The authors further defined the location of the HCAR1 protein in the leptomeningeal fibroblast-like cells of the pia mater—the innermost layer of the meninges which supports blood vessel—as well as pericyte-like cells, previously shown to be involved in the control of blood flow and angiogenesis.

Kynurenin and kynurenic acid

The underlying cause of depression is difficult to elucidate as a combination of biological, psychological and environmental factors contribute to the pathogenesis of this disease. Notably however, depressed patients are usually less physically active, and the effectiveness of exercise programs in reducing depressive symptoms has been widely recognized. Kynurenine (KYN) is a metabolite of the amino acid L-tryptophan, primarily synthetized in the liver. The degradation of KYN follows two different pathways: one proceeds with the conversion of KYN to 3-hydroxykynurenine (3HK) and quinolinic acid (QUIN), while the alternative pathway converts KYN to kynurenic acid (KYNA). In the brain, the conversion to KYNA is catalyzed by kynurenine aminotransferases (KATs) found in astrocytes. The same enzymes are expressed in different peripheral tissues including skeletal muscle. Importantly, evidence suggests that a dysregulation of the KYN pathway is associated with a number of psychiatric disorders such as depression. In a study from Agudelo et al., exercise has been shown to activate the expression of KATs through a PGC-1α- and PPARα/δ-dependent pathway in both mouse and human muscles. Consistently, overexpression of PGC-1α and loss of PGC-1α, respectively, resulted in increased and decreased muscle KAT expression levels. The increase in KATs expression in the gain-of-function model shifted KYN metabolism toward enhanced synthesis of KYNA, which is unable to cross the blood-brain barrier, thereby reducing the accumulation of plasma KYN with its neurotoxic effects on the brain. Remarkably, this shift conferred resistance to chronic mild stress-induced depression in mice overexpressing PGC-1α in their muscles. The authors furthermore demonstrated that muscle PGC-1α elevation prevented the alterations in the expression of neurotrophic, synaptic and pro-inflammatory markers in the hippocampus in response to chronic mild stress and, to a lesser extent, exogenous KYN administration. These data suggest that physical exercise could also affect neuroinflammation [reviewed in].

These findings further illustrate how muscle PGC-1α can mediate the benefits of exercise in the crosstalk between skeletal muscle and the brain. Incidentally, a new observation in healthy individuals confirmed that regular endurance training promotes skeletal muscle KATs gene and protein expression, along with enhanced peripheral conversion of KYN to KYNA. Moreover, the “detoxifying” potential of skeletal muscle may not be limited to KYNA, as muscle PGC-1α also regulates systemic ketone body levels and can prevent hyperketosis.

β-hydroxybutyrate

The transcriptional regulation of BDNF in the hippocampus at least in part depends on the modulation of histone acetylation. By comparing sedentary mice to mice that had running-wheel access for 30 days, Sleiman et al. found that exercise induced changes in class I HDAC expression, a family of proteins that suppress gene expression by deacetylating lysine residues on histone and non-histone proteins. In particular, binding of HDAC2 and HDAC3 to the hippocampal Bdnf promoter I and II was reduced in exercising mice, leading to elevated BDNF levels. Interestingly, besides its role as energy source, the ketone body BOHB also acts as an epigenetic signaling molecule by inhibiting class I HDACs. Sleiman and colleagues hypothesized that this exercise factor might inhibit the action of the histone deacetylases on the Bdnf promoter. They showed that exercise induces BOHB accumulation in the hippocampus and that the direct injection of BOHB into the ventricles of mice led to higher BDNF expression. In addition, application of BOHB to primary neurons decreased HDAC3 binding to the Bdnf promoter, whereas the use of a selective HDAC3-inhibitor or the knockdown of HDAC3 by shRNA increased BDNF expression. This effect on BDNF expression appeared specific, as BOHB did not induce Pgc-1α, Fndc5, or Errα mRNA in primary neurons. The authors also found that the increase of BDNF by BOHB led to enhanced glutamate release in hippocampal slices, and that this effect was dependent on TrkB signaling. The potential of BOHB to convey peripheral information to the brain is further illustrated by other findings demonstrating that liver-derived BOHB modulates neural network-based prediction of feeding time in mice.

Muscle Bmal1

Sleep is a critical health function that is controlled by complex mechanisms distributed in multiple brain areas such as the cortex, the brain stem and the hypothalamus. Circadian clocks are located in nearly every cell of the mammalian body and generate molecular rhythms with a 24-h period, essential to adjust the behavior and physiology of an organism to the external environment. In the past, several studies in mice and humans have demonstrated the consequence of genetic clock perturbations on sleep homeostasis. In particular, global deletion of the core clock gene Bmal1 in mice can affect sleep processes, with longer non-rapid eye movement (NREM) sleep time and altered sleep response after a period of sleep loss. Recent findings from Ehlen et al. have challenged the common view that sleep is a process that is only influenced by the brain. They found that restoring Bmal1 expression in the brain of whole-body Bmal1 KO mice failed to normalize NREM sleep amount to control values, suggesting that Bmal1 in another tissue might be important to regulate sleep physiology. Indeed, rescuing Bmal1 in skeletal muscle was sufficient to restore NREM sleep amount as well as sleep recovery after sleep loss. A causative role for muscle Bmal1 was further supported by the fact that Bmal1 deletion only in skeletal muscle recapitulated the sleep alterations seen in whole-body Bmal1 KO mice, whereas overexpression of Bmal1 in skeletal muscle of wild-type mice renders mice resistant to sleep deprivation.

These results are intriguing for several reasons. First, they suggest for the first time that a single gene in a peripheral tissue can modulate essential centrally-generated sleep processes—whether this depends on the BMAL1 association with CLOCK or other partners in muscle cells has to be investigated. Second, these data imply a muscle-to-brain signaling involved in sleep regulation, either humoral, or, based on the observation that mice lacking Bmal1 in their muscles exhibit potent metabolic disruptions, via metabolites. Third, because restoring Bmal1 expression in muscle cells does not restore circadian rhythmicity, and more importantly here, the diurnal rhythm of NREM sleep, it is possible that the production and secretion of this muscle-derived factor is a time-controlled cellular event. In the same line of thought, it would be interesting to evaluate whether scheduled exercise, in addition to muscle Bmal1 reintroduction, is able to reinstate sleep phase timing in this mouse model.

Cytokines

Contraction-induced release of IL-6 has potent effects on whole-body glucose disposal. Interestingly, IL-6 can act locally on muscle cell glucose uptake and fatty acid oxidation in an autocrine/paracrine manner. Systemic elevation of IL-6 by exogenous administration or exercise stimulates insulin release from pancreatic cells and mediates fasting-induced free fatty acid mobilization by adipose tissue as an endocrine hormone. Importantly, other cytokines, e.g., IL-8 and IL-15 mRNA, are also upregulated upon exercise in skeletal muscle and have the potential to behave as myokines [reviewed in]. Additional evidence suggests that the murine chemokine CXC ligand 1 (CXCL-1) and the leukemia inhibitory factor (LIF)—belonging to the IL-6 cytokine superfamily—are both produced by contracting muscle cells and may exert local or long-distance actions [reviewed in]. Likewise, in vitro data from primary human myotubes further suggest a broader muscle cytokines response to exercise. Interestingly, most of these cytokines are neuromodulators when expressed by neurons and glial cells, potentially influencing brain health and disease. This is especially evidenced in the context of higher central or peripheral level of pro-inflammatory cytokines, which reduce central BDNF expression and thus impact on neurogenesis and neurotransmitter release. It is currently unclear whether all of these cytokines are released from muscle fibers or from resident immune cells in this tissue. Moreover, a potential crosstalk between muscle and brain remains to be shown: potentially, cytokine signaling at the blood-brain interface might be important to modulate aspects of brain physiology such as sleep, memory or feeding behavior.

FGF21

Fibroblast growth factor 21 (FGF21) is an endocrine hormone expressed by several tissues including skeletal muscle, adipose tissue and pancreas. The main source of FGF21 is the liver during prolonged fasting, presumably via PPARα- and PGC-1α-dependent mechanisms, resulting in a modulation of systemic energy balance, insulin sensitivity, hepatic gluconeogenesis and glucocorticoid levels. Importantly, FGF21 can cross the blood-brain barrier and is found in both human and mouse cerebrospinal fluid. Moreover, FGF21 signals in the brain through its co-receptor, βKlotho, as well as the FGF receptor-1, located in the hypothalamus. Proposed effects for FGF21 in the nervous system are the modulation of the sympathetic nerve input to brown adipose tissue, the control of circadian behavior, and neuroprotection. Studies also suggest that FGF21 can be produced by muscle cells in certain context involving e.g., the activation of AKT or the mTORC1 pathway. Pereira et al. demonstrated that a muscle deficiency of the mitochondrial fusion protein optic atrophy 1 (OPA1) alters mitochondrial dynamics and increases endoplasmic reticulum (ER) stress, thereby promoting muscle-FGF21 release and rendering mice resistant to age- and diet-induced obesity and insulin resistance. The molecular mechanism by which ER-stress activates FGF21 is not clear, but could involve the transcriptional co-regulator PGC-1α. Of interest, one study showed increase serum FGF21 levels in mice and humans after exercise, yet likely of liver and not skeletal muscle or adipose tissue origin. In summary, FGF21 can be considered as an hepatokine, adipokine, and potentially a myokine, and has various effects at the whole-body level including the nervous system. Thereby, future research should investigate the putative involvement of FGF21 in the muscle-brain crosstalk, especially during exercise.

Inter-cell crosstalk

Skeletal muscle is a part of a larger system which also encompasses bones, tendons, ligaments, cartilage, joints, nervous and connective tissues. In particular, beyond their mechanical coupling, bone and muscle cells can communicate at the biochemical and molecular levels underlining a potential paracrine/endocrine crosstalk. Different studies demonstrated an effect of muscle-specific gene deletion or overexpression on bone physiology [reviewed in], and a close correlation between bone and muscle deterioration during aging. As in other cell types, different bone cell types have the capacity to release factors into the circulation. For instance, the osteoblast-secreted protein osteocalcin is essential to regulate energy metabolism by increasing insulin sensitivity via the stimulation of adiponectin release by adipocytes. Intriguingly, mouse and human data showed that circulating osteocalcin levels are increased upon exercise, and greatly diminished during aging. Moreover, bone-derived osteocalcin signals to muscle cells and favors the uptake and utilization of glucose and fatty acids in addition to stimulate muscle secretion of IL-6, which again feedbacks to bone cells to enhance osteocalcin production. Mosialou et al. revealed that the bone-derived glycoprotein lipocalin 2 (LCN2), a previously identified component of the immune response, crosses the blood-brain barrier and binds to the melanocortin 4 receptor (MC4R) in the paraventricular and ventromedial neurons of the hypothalamus to inhibit food intake. Lipocalin 2 is also produced in muscle cells under the control of PGC-1α.

These findings implicate crosstalk of skeletal muscle with more dispersed peripheral cells. For instance, physical exercise induces the secretion of the adipose-derived hormone adiponectin, which enhances hippocampal neurogenesis and has potent antidepressant effects. Interestingly, a role for muscle IL-15 has been suggested in the regulation of adiponectin production.

The circadian muscle secretome

Circadian clocks control myriad of processes such as gene regulation, protein synthesis and export, enzyme activity, cell signaling, nutrient accumulation, on a 24-h time scale. Moreover, clock proteins are cellular sensors, in that they can integrate specific changes in the external or internal environment. Chronic circadian disruption by irregular sleep-wake cycles or meal timing has been associated with obesity and other metabolic conditions, cancer and inflammation, sleep as well as cognitive and mental disorders. In skeletal muscle, the molecular clock has been linked to cell growth and repair, autophagy, insulin sensitivity, lipid homeostasis, mitochondrial metabolism and respiration. Moreover, scheduled exercise is a potent stimulus to regulate circadian timing in skeletal muscle. Interestingly, human primary myotubes harbor a cell-autonomous circadian clock involved in the basal release of cytokines (e.g., IL-6, IL-8) and other proteins (e.g., VEGF, FABP) as identified by ELISA and multiplex assays. Intriguingly, Pgc-1α transcript oscillates in skeletal muscle and PGC-1α can co-activate RORα to induce the expression of Bmal1 in primary hepatocytes. Furthermore, genetic ablation of Bmal1 from muscle cells gave evidence that a peripheral clock function is essential for centrally-controlled sleep processes. Thereby, it is likely that a transcriptional regulatory network, involving circadian nuclear receptors and the coactivator protein PGC-1α coordinates the time-of-day-dependent accumulation of myokines in muscle cells and secretion into the circulation. Future work should for instance evaluate the temporal phase relationship between core clock components and muscle-derived factors. Moreover, if part of the muscle secretome is gated by the circadian clock as in other endocrine organs, there are certainly time windows during which exercise can exert maximal effects on brain physiology.

Altogether, there is a likely bidirectional influence between circadian and exercise pathways in muscle cells—whether this is important for skeletal muscle endocrine function requires further investigation. In any case, at the organismal level, circadian clocks clearly provide a molecular basis by which endocrine signaling—i.e., from the production and secretion of an endocrine factor to the activation of a signaling pathway—can be achieved in a timely fashion. Given the conserved relation between circadian clock and neuronal function, time-based physical activity interventions may potentiate the health benefits of exercise.

Conclusion

Genetic engineering and the relentless motivation of captive rodents to be active on an exercise wheel have given scientists the opportunity to identify several muscle-derived signaling factors (Figure 1). At the central level, BDNF is a crucial mediator of the effects of exercise for the modulation of synaptic transmission, neurogenesis and memory function. In skeletal muscle, PGC-1α exerts a strong “detoxifying” potential and is an effective regulator of the muscle secretome, essential for exercise adaptations and the regulation of central function such as memory and mood. However, the timing and regulation of myokine production and secretion are still poorly understood. For many putative myokines, a thorough characterization and validation is still lacking [discussed in]. Moreover, discrepancies in the identification of putative myokines have been emerging in studies in cell-based compared to in vivo models. Finally, for most of these factors it is unclear whether peripheral or central production is mediating the beneficial effects on the brain. Nevertheless, the strong epidemiological evidence of exercise as a powerful intervention to prevent and treat various pathologies warrants a careful dissection of the signals, networks and mediators of the inter-organ crosstalk originating from skeletal muscle. This is of particular importance for neurological disorders, where therapeutic options are scarce and desperately needed.

Author contributions

All authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References 202

  1. 1.

    Ding D Lawson KD Kolbe-Alexander TL Finkelstein EA Katzmarzyk PT van Mechelen W. The economic burden of physical inactivity: a global analysis of major non-communicable diseases. Lancet (2016 ) 388:1311–24.

    Not in our library10.1016/s0140-6736(16)30383-x

  2. 2.

    Lobelo F Stoutenberg M Hutber A. The exercise is medicine global health initiative: a 2014 update. Br J Sports Med. (2014 ) 48:1627–33.

    Not in our library10.1136/bjsports-2013-093080

  3. 3.

    Pedersen BK Saltin B. Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports (2015 ) 25 (Suppl. 3):1–72.

    Not in our library10.1111/sms.12581

  4. 4.

    Sallis RE. Exercise is medicine and physicians need to prescribe it! Br J Sports Med. (2009 ) 43:3–4.

    Not in our library10.1136/bjsm.2008.054825

  5. 5.
    Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults · 2017
    No notice
  6. 6.

    Lobstein T Baur L Uauy R. Obesity in children and young people: a crisis in public health. Obesity Rev. (2004 ) 5:4–85.

    Not in our library10.1111/j.1467-789x.2004.00133.x

  7. 7.

    Ekelund U Steene-Johannessen J Brown WJ Fagerland MW Owen N Powell KE. Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? A harmonised meta-analysis of data from more than 1 million men and women. Lancet (2016 ) 388:1302–10.

    Not in our library10.1016/s0140-6736(16)30370-1

  8. 8.

    Handschin C Spiegelman BM. The role of exercise and PGC1alpha in inflammation and chronic disease. Nature (2008 ) 454:463–9.

    Not in our library10.1038/nature07206

  9. 9.

    Warburton DE Nicol CW Bredin SS. Health benefits of physical activity: the evidence. CMAJ (2006 ) 174:801–9.

    Not in our library10.1503/cmaj.051351

  10. 10.

    Koopman R. van Loon L. J. Aging, exercise, and muscle protein metabolism. J Appl Physiol. (1985 ) (2009 ) 106:2040–8.

    Not in our library10.1152/japplphysiol.91551.2008

  11. 11.

    Rooyackers OE Nair KS. Hormonal regulation of human muscle protein metabolism. Annu Rev Nutr. (1997 ) 17:457–85.

    Not in our library10.1146/annurev.nutr.17.1.457

  12. 12.

    Bassel-Duby R Olson EN. Signaling pathways in skeletal muscle remodeling. Annu Rev Biochem. (2006 ) 75:19–37.

    Not in our library10.1146/annurev.biochem.75.103004.142622

  13. 13.

    Hawley JA Hargreaves M Joyner MJ Zierath JR. Integrative biology of exercise. Cell (2014 ) 159:738–49.

    Not in our library10.1016/j.cell.2014.10.029

  14. 14.

    Whitham M Febbraio MA. The ever-expanding myokinome: discovery challenges and therapeutic implications. Nat Rev Drug Discov. (2016 ) 15:719–29.

    Not in our library10.1038/nrd.2016.153

  15. 15.

    Sylow L Kleinert M Richter EA Jensen TE. Exercise-stimulated glucose uptake - regulation and implications for glycaemic control. Nat Rev Endocrinol. (2017 ) 13:133–48.

    Not in our library10.1038/nrendo.2016.162

  16. 16.

    Egan B Zierath JR. Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab. (2013 ) 17:162–84.

    Not in our library10.1016/j.cmet.2012.12.012

  17. 17.

    Henriksson J. Effect of exercise on amino acid concentrations in skeletal muscle and plasma. J Exp Biol. (1991 ) 160:149–65.

    Not in our library10.1242/jeb.160.1.149

  18. 18.

    Lewis GD Farrell L Wood MJ Martinovic M Arany Z Rowe GC. Metabolic signatures of exercise in human plasma. Sci Transl Med. (2010 ) 2:33ra37.

    Not in our library10.1126/scitranslmed.3001006

  19. 19.

    Schurr A. Lactate: the ultimate cerebral oxidative energy substrate? J Cereb Blood Flow Metab. (2006 ) 26:142–52.

    Not in our library10.1038/sj.jcbfm.9600174

  20. 20.

    van Hall G Stromstad M Rasmussen P Jans O Zaar M Gam C. Blood lactate is an important energy source for the human brain. J Cereb Blood Flow Metab. (2009 ) 29:1121–9.

    Not in our library10.1038/jcbfm.2009.35

  21. 21.

    Bergersen LH. Lactate transport and signaling in the brain: potential therapeutic targets and roles in body-brain interaction. J Cereb Blood Flow Metab. (2015 ) 35:176–85.

    Not in our library10.1038/jcbfm.2014.206

  22. 22.

    Takimoto M Hamada T. Acute exercise increases brain region-specific expression of MCT1, MCT2, MCT4, GLUT1, and COX IV proteins. J Appl Physiol. (2014 ).116:1238–50.

    Not in our library10.1152/japplphysiol.01288.2013

  23. 23.

    Newman JC Verdin E. β-Hydroxybutyrate: a signaling metabolite. Annu Rev Nutr. (2017 ) 37:51–76.

    Not in our library10.1146/annurev-nutr-071816-064916

  24. 24.

    Barros LF. Metabolic signaling by lactate in the brain. Trends Neurosci. (2013 ) 36:396–404.

    Not in our library10.1016/j.tins.2013.04.002

  25. 25.

    Ruan GX Kazlauskas A. Lactate engages receptor tyrosine kinases Axl, Tie2, and vascular endothelial growth factor receptor 2 to activate phosphoinositide 3-kinase/Akt and promote angiogenesis. J Biol Chem. (2013 ) 288:21161–72.

    Not in our library10.1074/jbc.m113.474619

  26. 26.

    Brasse-Lagnel C Lavoinne A Husson A. Control of mammalian gene expression by amino acids, especially glutamine. Febs j (2009 ) 276:1826–44.

    Not in our library10.1111/j.1742-4658.2009.06920.x

  27. 27.

    Curi R Newsholme P Procopio J Lagranha C Gorjao R Pithon-Curi TC. Glutamine, gene expression, and cell function. Front Biosci J Virtual Libr. (2007 ) 12:344–57.

    Not in our library10.2741/2068

  28. 28.

    Swiatkiewicz M Fiedorowicz M Orzeł J Wełniak-Kaminska M Bogorodzki P Langfort J. Increases in brain 1H-MR glutamine and glutamate signals following acute exhaustive endurance exercise in the rat. Front Physiol. (2017 ) 8:19.

    Not in our library10.3389/fphys.2017.00019

  29. 29.

    Hawkins RA. The blood-brain barrier and glutamate. Am J Clin Nutr. (2009 ) 90:867S−74S.

    Not in our library10.3945/ajcn.2009.27462bb

  30. 30.

    Machler P Wyss MT Elsayed M Stobart J Gutierrez R von Faber-Castell A. In vivo evidence for a lactate gradient from astrocytes to neurons. Cell Metab. (2016 ) 23:94–102.

    Not in our library10.1016/j.cmet.2015.10.010

  31. 31.

    Matsui T Ishikawa T Ito H Okamoto M Inoue K Lee MC. Brain glycogen supercompensation following exhaustive exercise. J Physiol. (2012 ) 590:607–16.

    Not in our library10.1113/jphysiol.2011.217919

  32. 32.

    Suzuki A Stern SA Bozdagi O Huntley GW Walker RH Magistretti PJ. Astrocyte-neuron lactate transport is required for long-term memory formation. Cell (2011 ) 144:810–23.

    Not in our library10.1016/j.cell.2011.02.018

  33. 33.

    Matsui T Omuro H Liu Y-F Soya M Shima T McEwen BS. Astrocytic glycogen-derived lactate fuels the brain during exhaustive exercise to maintain endurance capacity. Proc Natl Acad Sci USA. (2017 ) 114:6358–63.

    Not in our library10.1073/pnas.1702739114

  34. 34.

    Barres R Yan J Egan B Treebak JT Rasmussen M Fritz T. Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab. (2012 ) 15:405–11.

    Not in our library10.1016/j.cmet.2012.01.001

  35. 35.

    Camera DM Burniston JG Pogson MA Smiles WJ Hawley JA. Dynamic proteome profiling of individual proteins in human skeletal muscle after a high-fat diet and resistance exercise. Faseb J. (2017 ) 31:5478–94.

    Not in our library10.1096/fj.201700531r

  36. 36.

    Choi S Liu X Li P Akimoto T Lee SY Zhang M. Transcriptional profiling in mouse skeletal muscle following a single bout of voluntary running: evidence of increased cell proliferation. J Appl Physiol. (2005 ) 99:2406–15.

    Not in our library10.1152/japplphysiol.00545.2005

  37. 37.

    Hody S Leprince P Sergeant K Renaut J Croisier JL Wang F. Human muscle proteome modifications after acute or repeated eccentric exercises. Med Sci Sports Exerc. (2011 ) 43:2281–96.

    Not in our library10.1249/mss.0b013e318222edf3

  38. 38.

    Laker RC Garde C Camera DM Smiles WJ Zierath JR Hawley JA. Transcriptomic and epigenetic responses to short-term nutrient-exercise stress in humans. Sci Rep. (2017 ) 7:15134.

    Not in our library10.1038/s41598-017-15420-7

  39. 39.

    Lundberg TR Fernandez-Gonzalo R Tesch PA Rullman E Gustafsson T. Aerobic exercise augments muscle transcriptome profile of resistance exercise. Am J Physiol Regul Integr Comp Physiol. (2016 ) 310:R1279–87.

    Not in our library10.1152/ajpregu.00035.2016

  40. 40.

    Koh JH Hancock CR Terada S Higashida K Holloszy JO Han DH. PPARbeta Is Essential for maintaining normal levels of PGC-1alpha and mitochondria and for the increase in muscle mitochondria induced by exercise. Cell Metab. (2017 ) 25:1176–85.e1175.

    Not in our library10.1016/j.cmet.2017.04.029

  41. 41.

    Perez-Schindler J Svensson K Vargas-Fernandez E Santos G Wahli W Handschin C. The coactivator PGC-1alpha regulates skeletal muscle oxidative metabolism independently of the nuclear receptor PPARbeta/delta in sedentary mice fed a regular chow diet. Diabetologia (2014 ) 57:2405–12.

    Not in our library10.1007/s00125-014-3352-3

  42. 42.

    Schuler M Ali F Chambon C Duteil D Bornert JM Tardivel A. PGC1alpha expression is controlled in skeletal muscles by PPARbeta, whose ablation results in fiber-type switching, obesity, and type 2 diabetes. Cell Metab. (2006 ) 4:407–14.

    Not in our library10.1016/j.cmet.2006.10.003

  43. 43.

    Wright DC Han DH Garcia-Roves PM Geiger PC Jones TE Holloszy JO. Exercise-induced mitochondrial biogenesis begins before the increase in muscle PGC-1alpha expression. J Biol Chem. (2007 ) 282:194–9.

    Not in our library10.1074/jbc.m606116200

  44. 44.

    Kupr B Handschin C. Complex coordination of cell plasticity by a PGC-1α-controlled transcriptional network in skeletal muscle. Front Physiol. (2015 ) 6:325.

    Not in our library10.3389/fphys.2015.00325

  45. 45.

    Kupr B Schnyder S Handschin C. Role of nuclear receptors in exercise-induced muscle adaptations. Cold Spring Harb Perspect Med. (2017 ) 7:a029835.

    Not in our library10.1101/cshperspect.a029835

  46. 46.

    Schnyder S Kupr B Handschin C. Coregulator-mediated control of skeletal muscle plasticity - a mini-review. Biochimie (2017 ) 136:49–54.

    Not in our library10.1016/j.biochi.2016.12.011

  47. 47.

    Summermatter S Santos G Pérez-Schindler J Handschin C. Skeletal muscle PGC-1α controls whole-body lactate homeostasis through estrogen-related receptor α-dependent activation of LDH B and repression of LDH A. Proc Natl Acad Sci USA (2013 ) 110:8738–43.

    Not in our library10.1073/pnas.1212976110

  48. 48.

    Arany Z Foo SY Ma Y Ruas JL Bommi-Reddy A Girnun G. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature (2008 ) 451:1008–12.

    Not in our library10.1038/nature06613

  49. 49.

    Chinsomboon J Ruas J Gupta RK Thom R Shoag J Rowe GC. The transcriptional coactivator PGC-1alpha mediates exercise-induced angiogenesis in skeletal muscle. Proc Natl Acad Sci USA (2009 ) 106:21401–6.

    Not in our library10.1073/pnas.0909131106

  50. 50.

    Rowe GC Raghuram S Jang C Nagy JA Patten IS Goyal A. PGC-1α induces SPP1 to activate macrophages and orchestrate functional angiogenesis in skeletal muscle. Circ Res. (2014 ) 115:504–17.

    Not in our library10.1161/circresaha.115.303829

  51. 51.

    Arnold AS Gill J Christe M Ruiz R McGuirk S St-Pierre J. Morphological and functional remodelling of the neuromuscular junction by skeletal muscle PGC-1α. Nat Commun (2014 ) 5:3569.

    Not in our library10.1038/ncomms4569

  52. 52.

    Mills R Taylor-Weiner H Correia JC Agudelo LZ Allodi I Kolonelou C. Neurturin is a PGC-1α1-controlled myokine that promotes motor neuron recruitment and neuromuscular junction formation. Mol Metab. (2017 ) 7:12–22.

    Not in our library10.1016/j.molmet.2017.11.001

  53. 53.

    Jäger S Handschin C St.-Pierre J Spiegelman BM. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α. Proc Natl Acad Sci. (2007 ) 104:12017–22.

    Not in our library10.1073/pnas.0705070104

  54. 54.

    Nemoto S Fergusson MM Finkel T. SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1α. J Biol Chem. (2005 ) 280:16456–60.

    Not in our library10.1074/jbc.m501485200

  55. 55.

    Richter EA Ruderman NB. AMPK and the biochemistry of exercise: implications for human health and disease. Biochem J. (2009 ) 418:261–75.

    Not in our library10.1042/bj20082055

  56. 56.

    Fan W Waizenegger W Lin CS Sorrentino V He M-X Wall CE. PPARδ promotes running endurance by preserving glucose. Cell Metab. (2017 ) 25:1186–93.e1184.

    Not in our library10.1016/j.cmet.2017.04.006

  57. 57.

    Handschin C. Caloric restriction and exercise “mimetics”: ready for prime time? Pharmacol Res. (2016 ) 103:158–66.

    Not in our library10.1016/j.phrs.2015.11.009

  58. 58.

    Kobilo T Yuan C van Praag H. Endurance factors improve hippocampal neurogenesis and spatial memory in mice. Learn Mem. (2011 ) 18:103–7.

    Not in our library10.1101/lm.2001611

  59. 59.

    Kobilo T Guerrieri D Zhang Y Collica SC Becker KG van Praag H. AMPK agonist AICAR improves cognition and motor coordination in young and aged mice. Learn Mem. (2014 ) 21:119–26.

    Not in our library10.1101/lm.033332.113

  60. 60.
    Physical activity and mental health: the association between exercise and mood Atividade física e saúde mental: a associação entre exercício e humor · 2005
    Not checked
  61. 61.

    Taylor CB Sallis JF Needle R. The relation of physical activity and exercise to mental health. Public Health Rep. (1985 ) 100:195–202.

    Not in our library

  62. 62.

    Erickson KI Voss MW Prakash RS Basak C Szabo A Chaddock L. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci USA. (2011 ) 108:3017–22.

    Not in our library10.1073/pnas.1015950108

  63. 63.

    Firth J Stubbs B Vancampfort D Schuch F Lagopoulos J Rosenbaum S. Effect of aerobic exercise on hippocampal volume in humans: a systematic review and meta-analysis. NeuroImage (2018 ) 166:230–8.

    Not in our library10.1016/j.neuroimage.2017.11.007

  64. 64.
    A systematic review of MRI studies examining the relationship between physical fitness and activity and the white matter of the ageing brain · 2016
    No notice
  65. 65.

    van Praag H Christie BR Sejnowski TJ Gage FH. Running enhances neurogenesis, learning, and long-term potentiation in mice. Proc Natl Acad Sci USA. (1999 ) 96:13427–31.

    Not in our library10.1073/pnas.96.23.13427

  66. 66.

    van Praag H Kempermann G Gage FH. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nat Neurosci. (1999 ) 2:266–70.

    Not in our library10.1038/6368

  67. 67.

    Eisinger BE Zhao X. Identifying molecular mediators of environmentally enhanced neurogenesis Cell Tissue Res. (2018 ). 371:7–21.

    Not in our library10.1007/s00441-017-2718-5

  68. 68.

    Bramham CR Messaoudi E. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol. (2005 ) 76:99–125.

    Not in our library10.1016/j.pneurobio.2005.06.003

  69. 69.

    Lu B Nagappan G Lu Y. BDNF and synaptic plasticity, cognitive function, and dysfunction. In: GR Lewin Carter BD, editors. Neurotrophic Factors. Berlin; Heidelberg: Springer (2014 ), p. 223–50.

    Not in our library10.1007/978-3-642-45106-5_9

  70. 70.

    Matsumoto T Rauskolb S Polack M Klose J Kolbeck R Korte M. Biosynthesis and processing of endogenous BDNF: CNS neurons store and secrete BDNF, not pro-BDNF. Nat Neurosci. (2008 ) 11:131–3.

    Not in our library10.1038/nn2038

  71. 71.

    Yang J Siao CJ Nagappan G Marinic T Jing D McGrath K. Neuronal release of proBDNF. Nat Neurosci. (2009 ) 12:113–5.

    Not in our library10.1038/nn.2244

  72. 72.

    Neeper SA Góauctemez-Pinilla F Choi J Cotman C. Exercise and brain neurotrophins. Nature (1995 ) 373:109.

    Not in our library10.1038/373109a0

  73. 73.

    Vaynman S Ying Z Gomez-Pinilla F. Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition. Eur J Neurosci. (2004 ) 20:2580–90.

    Not in our library10.1111/j.1460-9568.2004.03720.x

  74. 74.

    Rasmussen P Brassard P Adser H Pedersen MV Leick L Hart E. Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Exp Physiol. (2009 ) 94:1062–9.

    Not in our library10.1113/expphysiol.2009.048512

  75. 75.

    Seifert T Brassard P Wissenberg M Rasmussen P Nordby P Stallknecht B. Endurance training enhances BDNF release from the human brain. Am J Physiol Regul Integr Comp Physiol. (2009 ) 298:R372–7.

    Not in our library10.1152/ajpregu.00525.2009

  76. 76.

    Klein AB Williamson R Santini MA Clemmensen C Ettrup A Rios M. Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol. (2011 ) 14:347–53.

    Not in our library10.1017/s1461145710000738

  77. 77.
    Brain-derived Neurotrophic Factor in Megakaryocytes · 2016
    No notice
  78. 78.

    El-Sayed MS Ali N El-Sayed Ali Z. Aggregation and activation of blood platelets in exercise and training. Sports Med. (2005 ) 35:11–22.

    Not in our library10.2165/00007256-200535010-00002

  79. 79.

    Yáñez-Mó M Siljander PRM Andreu Z Bedina Zavec A Borràs FE Buzas EI. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles (2015 ) 4:27066.

    Not in our library10.3402/jev.v4.27066

  80. 80.

    Ogborn DI Gardiner PF. Effects of exercise and muscle type on BDNF, NT-4/5, and TrKB expression in skeletal muscle. Muscle Nerve (2010 ) 41:385–91.

    Not in our library10.1002/mus.21503

  81. 81.

    Pedersen BK Pedersen M Krabbe KS Bruunsgaard H Matthews VB Febbraio MA. Role of exercise-induced brain-derived neurotrophic factor production in the regulation of energy homeostasis in mammals. Exp Physiol. (2009 ) 94:1153–60.

    Not in our library10.1113/expphysiol.2009.048561

  82. 82.

    Matthews VB Astrom MB Chan MH Bruce CR Krabbe KS Prelovsek O. Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase. Diabetologia (2009 ) 52:1409–18.

    Not in our library10.1007/s00125-009-1364-1

  83. 83.

    Mousavi K Jasmin BJ. BDNF is expressed in skeletal muscle satellite cells and inhibits myogenic differentiation. J Neurosci. (2006 ) 26:5739–49.

    Not in our library10.1523/jneurosci.5398-05.2006

  84. 84.

    Koliatsos VE Clatterbuck RE Winslow JW Cayouette MH Price DL. Evidence that brain-derived neurotrophic factor is a trophic factor for motor neurons in vivo. Neuron (1993 ) 10:359–67.

    Not in our library10.1016/0896-6273(93)90326-m

  85. 85.

    Givalois L Arancibia S Alonso G Tapia-Arancibia L. Expression of brain-derived neurotrophic factor and its receptors in the median eminence cells with sensitivity to stress. Endocrinology (2004 ) 145:4737–47.

    Not in our library10.1210/en.2004-0616

  86. 86.

    Ding Q Vaynman S Akhavan M Ying Z Gomez-Pinilla F. Insulin-like growth factor I interfaces with brain-derived neurotrophic factor-mediated synaptic plasticity to modulate aspects of exercise-induced cognitive function. Neuroscience (2006 ) 140:823–33.

    Not in our library10.1016/j.neuroscience.2006.02.084

  87. 87.

    Trejo JL Carro E Torres-Aleman I. Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. J Neurosci (2001 ) 21:1628–34.

    Not in our library10.1523/jneurosci.21-05-01628.2001

  88. 88.

    Cheng A Wan R Yang JL Kamimura N Son TG Ouyang X. Involvement of PGC-1alpha in the formation and maintenance of neuronal dendritic spines. Nat Commun. (2012 ) 3:1250.

    Not in our library10.1038/ncomms2238

  89. 89.

    Wrann CD White JP Salogiannnis J Laznik-Bogoslavski D Wu J Ma D. Exercise induces hippocampal BDNF through a PGC-1alpha/FNDC5 pathway. Cell Metab. (2013 ) 18:649–59.

    Not in our library10.1016/j.cmet.2013.09.008

  90. 90.

    St-Pierre J Drori S Uldry M Silvaggi JM Rhee J Jager S. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell (2006 ) 127:397–408.

    Not in our library10.1016/j.cell.2006.09.024

  91. 91.

    Adlard PA Perreau VM Pop V Cotman CW. Voluntary exercise decreases amyloid load in a transgenic model of alzheimer's disease. J Neurosci. (2005 ) 25:4217–21.

    Not in our library10.1523/jneurosci.0496-05.2005

  92. 92.

    Pang TY Stam NC Nithianantharajah J Howard ML Hannan AJ. Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington's disease transgenic mice. Neuroscience (2006 ) 141:569–84.

    Not in our library10.1016/j.neuroscience.2006.04.013

  93. 93.

    Praag HV Shubert T Zhao C Gage FH. Exercise enhances learning and hippocampal neurogenesis in aged mice. J Neurosci Official J Soc Neurosci. (2005 )25:8680–5.

    Not in our library10.1523/jneurosci.1731-05.2005

  94. 94.

    Duzel E van Praag H Sendtner M. Can physical exercise in old age improve memory and hippocampal function? Brain (2016 ) 139:662–73.

    Not in our library10.1093/brain/awv407

  95. 95.

    Erickson KI Prakash RS Voss MW Chaddock L Hu L Morris KS. Aerobic fitness is associated with hippocampal volume in elderly humans. Hippocampus (2009 ) 19:1030–9.

    Not in our library10.1002/hipo.20547

  96. 96.

    Prakash RS Voss MW Erickson KI Kramer AF. Physical activity and cognitive vitality. Annu Rev Psychol. (2015 ) 66:769–97.

    Not in our library10.1146/annurev-psych-010814-015249

  97. 97.

    Palmer TD Willhoite AR Gage FH. Vascular niche for adult hippocampal neurogenesis. J Comp Neurol. (2000 ) 425:479–94.

    Not in our library10.1002/1096-9861(20001002)425:4<479::aid-cne2>3.0.co;2-3

  98. 98.

    Kraus RM Stallings HW Yeager RC Gavin TP. Circulating plasma VEGF response to exercise in sedentary and endurance-trained men. J Appl Physiol. (2004 ) 96:1445–50.

    Not in our library10.1152/japplphysiol.01031.2003

  99. 99.

    Fabel K Fabel K Tam B Kaufer D Baiker A Simmons N. VEGF is necessary for exercise-induced adult hippocampal neurogenesis. Eur J Neurosci. (2003 ) 18:2803–12.

    Not in our library10.1111/j.1460-9568.2003.03041.x

  100. 100.

    Gomez-Pinilla F Ying Z Opazo P Roy RR Edgerton VR. Differential regulation by exercise of BDNF and NT-3 in rat spinal cord and skeletal muscle. Eur J Neurosci. (2001 ) 13:1078–84.

    Not in our library10.1046/j.0953-816x.2001.01484.x

  101. 101.

    McCullough MJ Peplinski NG Kinnell KR Spitsbergen JM. Glial cell line-derived neurotrophic factor protein content in rat skeletal muscle is altered by increased physical activity in vivo and in vitro. Neuroscience (2011 ) 174:234–44.

    Not in our library10.1016/j.neuroscience.2010.11.016

  102. 102.

    Tajiri N Yasuhara T Shingo T Kondo A Yuan W Kadota T. Exercise exerts neuroprotective effects on Parkinson's disease model of rats. Brain Res. (2010 ) 1310:200–7.

    Not in our library10.1016/j.brainres.2009.10.075

  103. 103.

    Ying Z Roy RR Edgerton VR Gomez-Pinilla F. Voluntary exercise increases neurotrophin-3 and its receptor TrkC in the spinal cord. Brain Res. (2003 ) 987:93–9.

    Not in our library10.1016/s0006-8993(03)03258-x

  104. 104.
    Neuroprotective effects of physical activity on the brain: a closer look at trophic factor signaling · 2014
    No notice
  105. 105.

    Febbraio MA Hiscock N Sacchetti M Fischer CP Pedersen BK. Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction. Diabetes (2004 ) 53:1643–8.

    Not in our library10.2337/diabetes.53.7.1643

  106. 106.

    Catoire M Mensink M Kalkhoven E Schrauwen P Kersten S. Identification of human exercise-induced myokines using secretome analysis. Physiol Genomics (2014 ) 46:256–67.

    Not in our library10.1152/physiolgenomics.00174.2013

  107. 107.
    Identification and Validation of Novel Contraction-Regulated Myokines Released from Primary Human Skeletal Muscle Cells · 2013
    No notice
  108. 108.

    Scheler M Irmler M Lehr S Hartwig S Staiger H Al-Hasani H. Cytokine response of primary human myotubes in an in vitro exercise model. Am J Physiol Cell Physiol. (2013 ) 305:C877–886.

    Not in our library10.1152/ajpcell.00043.2013

  109. 109.

    Norheim F Raastad T Thiede B Rustan AC Drevon CA Haugen F. Proteomic identification of secreted proteins from human skeletal muscle cells and expression in response to strength training. Am J Physiol Endocrinol Metab. (2011 ) 301:E1013–21.

    Not in our library10.1152/ajpendo.00326.2011

  110. 110.

    Roca-Rivada A Al-Massadi O Castelao C Senin LL Alonso J Seoane LM. Muscle tissue as an endocrine organ: comparative secretome profiling of slow-oxidative and fast-glycolytic rat muscle explants and its variation with exercise. J Proteomics (2012 ) 75:5414–25.

    Not in our library10.1016/j.jprot.2012.06.037

  111. 111.

    Pourteymour S Eckardt K Holen T Langleite T Lee S Jensen J. Global mRNA sequencing of human skeletal muscle: search for novel exercise-regulated myokines. Mol Metab. (2017 ) 6:352–65.

    Not in our library10.1016/j.molmet.2017.01.007

  112. 112.

    Schnyder S Handschin C. Skeletal muscle as an endocrine organ: PGC-1α, myokines and exercise. Bone (2015 ) 80:115–25.

    Not in our library10.1016/j.bone.2015.02.008

  113. 113.

    Roberts LD Bostrom P O'Sullivan JF Schinzel RT Lewis GD Dejam A. β -Aminoisobutyric acid induces browning of white fat and hepatic beta-oxidation and is inversely correlated with cardiometabolic risk factors. Cell Metab. (2014 ) 19:96–108.

    Not in our library10.1016/j.cmet.2013.12.003

  114. 114.

    Moon HY Becke A Berron D Becker B Sah N Benoni G. Running-induced systemic cathepsin B secretion is associated with memory function. Cell Metab. (2016 ) 24:332–40.

    Not in our library10.1016/j.cmet.2016.05.025

  115. 115.
    Exercise induces cerebral VEGF and angiogenesis via the lactate receptor HCAR1 · 2017
    No notice
  116. 116.
    Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body β-hydroxybutyrate · 2016
    No notice
  117. 117.

    Bookout AL de Groot MH Owen BM Lee S Gautron L Lawrence HL. FGF21 regulates metabolism and circadian behavior by acting on the nervous system. Nat Med. (2013 ) 19:1147–52.

    Not in our library10.1038/nm.3249

  118. 118.
    Acute Exercise Induces FGF21 Expression in Mice and in Healthy Humans · 2013
    No notice
  119. 119.

    Owen BM Ding X Morgan DA Coate KC Bookout AL Rahmouni K. FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss. Cell Metab. (2014 ) 20:670–7.

    Not in our library10.1016/j.cmet.2014.07.012

  120. 120.

    Carro E Nunez A Busiguina S Torres-Aleman I. Circulating insulin-like growth factor I mediates effects of exercise on the brain. J Neurosci (2000 ) 20:2926–33.

    Not in our library10.1523/jneurosci.20-08-02926.2000

  121. 121.

    Agudelo LZ Femenia T Orhan F Porsmyr-Palmertz M Goiny M Martinez-Redondo V. Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell (2014 ) 159:33–45.

    Not in our library10.1016/j.cell.2014.07.051

  122. 122.

    Schlittler M Goiny M Agudelo LZ Venckunas T Brazaitis M Skurvydas A. Endurance exercise increases skeletal muscle kynurenine aminotransferases and plasma kynurenic acid in humans. Am J Physiol Cell Physiol. (2016 ) 310:C836–40.

    Not in our library10.1152/ajpcell.00053.2016

  123. 123.
    Bmal1 function in skeletal muscle regulates sleep · 2017
    No notice
  124. 124.

    Ferrer-Martinez A Ruiz-Lozano P Chien KR. Mouse PeP: a novel peroxisomal protein linked to myoblast differentiation and development. Dev Dyn. (2002 ) 224:154–67.

    Not in our library10.1002/dvdy.10099

  125. 125.

    Teufel A Malik N Mukhopadhyay M Westphal H. Frcp1 and Frcp2, two novel fibronectin type III repeat containing genes. Gene (2002 ) 297:79–83.

    Not in our library10.1016/s0378-1119(02)00828-4

  126. 126.

    Bostrom P Wu J Jedrychowski MP Korde A Ye L Lo JC. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature (2012 ) 481:463–8.

    Not in our library10.1038/nature10777

  127. 127.

    Jedrychowski MP Wrann CD Paulo JA Gerber KK Szpyt J Robinson MM. Detection and Quantitation of Circulating Human Irisin by Tandem Mass Spectrometry. Cell Metab (2015 ) 22:734–40.

    Not in our library10.1016/j.cmet.2015.08.001

  128. 128.

    Lee P Linderman JD Smith S Brychta RJ Wang J Idelson C. Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metab. (2014 ) 19:302–9.

    Not in our library10.1016/j.cmet.2013.12.017

  129. 129.

    Perakakis N Triantafyllou GA Fernandez-Real JM Huh JY Park KH Seufert J. Physiology and role of irisin in glucose homeostasis. Nat Rev Endocrinol. (2017 ) 13:324–37.

    Not in our library10.1038/nrendo.2016.221

  130. 130.

    Hashemi MS Ghaedi K Salamian A Karbalaie K Emadi-Baygi M Tanhaei S. Fndc5 knockdown significantly decreased neural differentiation rate of mouse embryonic stem cells. Neuroscience (2013 ) 231:296–304.

    Not in our library10.1016/j.neuroscience.2012.11.041

  131. 131.

    Zhang W Chang L Zhang C Zhang R Li Z Chai B. Central and peripheral irisin differentially regulate blood pressure. Cardiovasc Drugs Ther. (2015 ) 29:121–7.

    Not in our library10.1007/s10557-015-6580-y

  132. 132.

    Turk V Stoka V Vasiljeva O Renko M Sun T Turk B. Cysteine cathepsins: from structure, function and regulation to new frontiers. Biochim Biophys Acta (2012 ) 1824:68–88.

    Not in our library10.1016/j.bbapap.2011.10.002

  133. 133.

    Aggarwal N Sloane BF. Cathepsin B: multiple roles in cancer. Proteomics Clin Appl. (2014 ) 8:427–37.

    Not in our library10.1002/prca.201300105

  134. 134.

    Theocharis AD Gialeli C Bouris P Giannopoulou E Skandalis SS Aletras AJ. Cell-matrix interactions: focus on proteoglycan-proteinase interplay and pharmacological targeting in cancer. FEBS J. (2014 ) 281:5023–42.

    Not in our library10.1111/febs.12927

  135. 135.

    Lauritzen KH Morland C Puchades M Holm-Hansen S Hagelin EM Lauritzen F. Lactate receptor sites link neurotransmission, neurovascular coupling, and brain energy metabolism. Cereb Cortex (2014 ) 24:2784–95.

    Not in our library10.1093/cercor/bht136

  136. 136.

    Wang L Chopp M Gregg SR Zhang RL Teng H Jiang A. Neural progenitor cells treated with EPO induce angiogenesis through the production of VEGF. J Cereb Blood Flow Metab. (2008 ) 28:1361–8.

    Not in our library10.1038/jcbfm.2008.32

  137. 137.

    Hall CN Reynell C Gesslein B Hamilton NB Mishra A Sutherland BA. Capillary pericytes regulate cerebral blood flow in health and disease. Nature (2014 ) 508:55–60.

    Not in our library10.1038/nature13165

  138. 138.

    Craft LL Perna FM. The benefits of exercise for the clinically depressed. Prim Care Companion J Clin Psychiatry (2004 ) 6:104–11.

    Not in our library10.4088/pcc.v06n0301

  139. 139.

    Josefsson T Lindwall M Archer T. Physical exercise intervention in depressive disorders: meta-analysis and systematic review. Scand J Med Sci Sports (2014 ) 24:259–72.

    Not in our library10.1111/sms.12050

  140. 140.

    Reus GZ Jansen K Titus S Carvalho AF Gabbay V Quevedo J. Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies. J Psychiatr Res (2015 ) 68:316–28.

    Not in our library10.1016/j.jpsychires.2015.05.007

  141. 141.

    Schwarcz R Bruno JP Muchowski PJ Wu HQ. Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci. (2012 ) 13:465–77.

    Not in our library10.1038/nrn3257

  142. 142.

    Cotman CW Berchtold NC Christie L-A. Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends in Neurosciences (2007 ) 30:464–72.

    Not in our library10.1016/j.tins.2007.06.011

  143. 143.

    Di Benedetto S Müller L Wenger E Düzel S Pawelec G. Contribution of neuroinflammation and immunity to brain aging and the mitigating effects of physical and cognitive interventions. NeurosciBiobehavl Rev. (2017 ) 75:114–28.

    Not in our library10.1016/j.neubiorev.2017.01.044

  144. 144.

    Svensson K Albert V Cardel B Salatino S Handschin C. Skeletal muscle PGC-1α modulates systemic ketone body homeostasis and ameliorates diabetic hyperketonemia in mice. Faseb J. (2016 ) 30:1976–86.

    Not in our library10.1096/fj.201500128

  145. 145.

    Koppel I Timmusk T. Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors. Neuropharmacology (2013 ) 75:106–15.

    Not in our library10.1016/j.neuropharm.2013.07.015

  146. 146.
    Liver-derived ketone bodies are necessary for food anticipation · 2016
    Not checked
  147. 147.

    Brown RE Basheer R McKenna JT Strecker RE McCarley RW. Control of sleep and wakefulness. Physiol Rev. (2012 ) 92:1087–187.

    Not in our library10.1152/physrev.00032.2011

  148. 148.

    Partch CL Green CB Takahashi JS. Molecular architecture of the mammalian circadian clock. Trends Cell Biol. (2014 ) 24:90–9.

    Not in our library10.1016/j.tcb.2013.07.002

  149. 149.

    Naylor E Bergmann BM Krauski K Zee PC Takahashi JS Vitaterna MH. The circadian clock mutation alters sleep homeostasis in the mouse. J Neurosci. (2000 ) 20:8138–43.

    Not in our library10.1523/jneurosci.20-21-08138.2000

  150. 150.

    Patke A Murphy PJ Onat OE Krieger AC Ozcelik T Campbell SS. Mutation of the human circadian clock gene CRY1 in familial delayed sleep phase disorder. Cell (2017 ) 169:203–15 e213.

    Not in our library10.1016/j.cell.2017.03.027

  151. 151.

    Laposky A Easton A Dugovic C Walisser J Bradfield C Turek F. Deletion of the mammalian circadian clock gene BMAL1/Mop3 alters baseline sleep architecture and the response to sleep deprivation. Sleep (2005 ) 28:395–409.

    Not in our library10.1093/sleep/28.4.395

  152. 152.

    Dyar KA Ciciliot S Wright LE Bienso RS Tagliazucchi GM Patel VR. Muscle insulin sensitivity and glucose metabolism are controlled by the intrinsic muscle clock. Mol Metab. (2014 ) 3:29–41.

    Not in our library10.1016/j.molmet.2013.10.005

  153. 153.
    Muscle-specific loss of Bmal1 leads to disrupted tissue glucose metabolism and systemic glucose homeostasis · 2016
    No notice
  154. 154.

    McDearmon EL Patel KN Ko CH Walisser JA Schook AC Chong JL. Dissecting the functions of the mammalian clock protein BMAL1 by tissue-specific rescue in mice. Science (2006 ) 314:1304–8.

    Not in our library10.1126/science.1132430

  155. 155.

    Carey AL Steinberg GR Macaulay SL Thomas WG Holmes AG Ramm G. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes (2006 ) 55:2688–97.

    Not in our library10.2337/db05-1404

  156. 156.

    Ellingsgaard H Hauselmann I Schuler B Habib AM Baggio LL Meier DT. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med. (2011 ) 17:1481–9.

    Not in our library10.1038/nm.2513

  157. 157.

    Wueest S Item F Boyle CN Jirkof P Cesarovic N Ellingsgaard H. Interleukin-6 contributes to early fasting-induced free fatty acid mobilization in mice. Am J Physiol Regul Integr Comp Physiol. (2014 ) 306:R861–7.

    Not in our library10.1152/ajpregu.00533.2013

  158. 158.

    Pedersen BK Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol. (2012 ) 8:457–65.

    Not in our library10.1038/nrendo.2012.49

  159. 159.

    Banks WA. Blood-brain barrier transport of cytokines: a mechanism for neuropathology. Curr Pharm Des. (2005 ) 11:973–84.

    Not in our library10.2174/1381612053381684

  160. 160.
    Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity · 2014
    No notice
  161. 161.

    Galic MA Riazi K Pittman QJ. Cytokines and brain excitability. Front Neuroendocrinol. (2012 ) 33:116–25.

    Not in our library10.1016/j.yfrne.2011.12.002

  162. 162.

    Fisher FM Maratos-Flier E. Understanding the Physiology of FGF21. Annu Rev Physiol. (2016 ) 78:223–41.

    Not in our library10.1146/annurev-physiol-021115-105339

  163. 163.

    Hsuchou H Pan W Kastin AJ. The fasting polypeptide FGF21 can enter brain from blood. Peptides (2007 ) 28:2382–6.

    Not in our library10.1016/j.peptides.2007.10.007

  164. 164.

    Tan BK Hallschmid M Adya R Kern W Lehnert H Randeva HS. Fibroblast growth factor 21 (FGF21) in human cerebrospinal fluid: relationship with plasma FGF21 and body adiposity. Diabetes (2011 ) 60:2758–62.

    Not in our library10.2337/db11-0672

  165. 165.

    Sa-Nguanmoo P Tanajak P Kerdphoo S Satjaritanun P Wang X Liang G. FGF21 improves cognition by restored synaptic plasticity, dendritic spine density, brain mitochondrial function and cell apoptosis in obese-insulin resistant male rats. Horm Behav. (2016 ) 85:86–95.

    Not in our library10.1016/j.yhbeh.2016.08.006

  166. 166.

    Guridi M Tintignac LA Lin S Kupr B Castets P Ruegg MA. Activation of mTORC1 in skeletal muscle regulates whole-body metabolism through FGF21. Sci Signal (2015 ) 8:ra113.

    Not in our library10.1126/scisignal.aab3715

  167. 167.

    Harris LA Skinner JR Shew TM Pietka TA Abumrad NA Wolins NE. Perilipin 5-driven lipid droplet accumulation in skeletal muscle stimulates the expression of fibroblast growth factor 21. Diabetes (2015 ) 64:2757–68.

    Not in our library10.2337/db14-1035

  168. 168.

    Izumiya Y Bina HA Ouchi N Akasaki Y Kharitonenkov A Walsh K. FGF21 is an Akt-regulated myokine. FEBS Lett. (2008 ) 582:3805–10.

    Not in our library10.1016/j.febslet.2008.10.021

  169. 169.

    Keipert S Ost M Johann K Imber F Jastroch M van Schothorst EM. Skeletal muscle mitochondrial uncoupling drives endocrine cross-talk through the induction of FGF21 as a myokine. Am J Physiol Endocrinol Metab. (2014 ) 306:E469–82.

    Not in our library10.1152/ajpendo.00330.2013

  170. 170.

    Pereira RO Tadinada SM Zasadny FM Oliveira KJ Pires KMP Olvera A. OPA1 deficiency promotes secretion of FGF21 from muscle that prevents obesity and insulin resistance. EMBO J. (2017 ) 36:2126–45.

    Not in our library10.15252/embj.201696179

  171. 171.

    Estall JL Ruas JL Choi CS Laznik D Badman M Maratos-Flier E. PGC-1α negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erb(α) axis. Proc Natl Acad Sci USA. (2009 ) 106:22510–5.

    Not in our library10.1073/pnas.0912533106

  172. 172.

    Wu J Ruas JL Estall JL Rasbach KA Choi JH Ye L. The unfolded protein response mediates adaptation to exercise in skeletal muscle through a PGC-1α/ATF6α complex. Cell Metab. (2011 ) 13:160–9.

    Not in our library10.1016/j.cmet.2011.01.003

  173. 173.

    Cianferotti L Brandi ML. Muscle-bone interactions: basic and clinical aspects. Endocrine (2014 ) 45:165–77.

    Not in our library10.1007/s12020-013-0026-8

  174. 174.

    Karasik D Kiel DP. Evidence for pleiotropic factors in genetics of the musculoskeletal system. Bone (2010 ) 46:1226–37.

    Not in our library10.1016/j.bone.2010.01.382

  175. 175.

    Novotny SA Warren GL Hamrick MW. Aging and the muscle-bone relationship. Physiology (2015 ) 30:8–16.

    Not in our library10.1152/physiol.00033.2014

  176. 176.

    Brotto M Bonewald L. Bone and muscle: Interactions beyond mechanical. Bone (2015 ) 80:109–14.

    Not in our library10.1016/j.bone.2015.02.010

  177. 177.

    Lee NK Sowa H Hinoi E Ferron M Ahn JD Confavreux C. Endocrine regulation of energy metabolism by the skeleton. Cell (2007 ) 130:456–69.

    Not in our library10.1016/j.cell.2007.05.047

  178. 178.

    Mera P Laue K Ferron M Confavreux C Wei J Galan-Diez M. Osteocalcin signaling in myofibers is necessary and sufficient for optimum adaptation to exercise. Cell Metab. (2016 ) 23:1078–92.

    Not in our library10.1016/j.cmet.2016.05.004

  179. 179.

    Mosialou I Shikhel S Liu JM Maurizi A Luo N He Z. MC4R-dependent suppression of appetite by bone-derived lipocalin 2. Nature (2017 ) 543:385–90.

    Not in our library10.1038/nature21697

  180. 180.

    Flo TH Smith KD Sato S Rodriguez DJ Holmes MA Strong RK. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature (2004 ) 432:917–21.

    Not in our library10.1038/nature03104

  181. 181.

    Furrer R Eisele PS Schmidt A Beer M Handschin C. Paracrine cross-talk between skeletal muscle and macrophages in exercise by PGC-1α-controlled BNP. Sci Rep. (2017 ) 7:40789.

    Not in our library10.1038/srep40789

  182. 182.

    Yau SY Li A Hoo RL Ching YP Christie BR Lee TM. Physical exercise-induced hippocampal neurogenesis and antidepressant effects are mediated by the adipocyte hormone adiponectin. Proc Natl Acad Sci USA. (2014 ) 111:15810–5.

    Not in our library10.1073/pnas.1415219111

  183. 183.

    Quinn LS Strait-Bodey L Anderson BG Argiles JM Havel PJ. Interleukin-15 stimulates adiponectin secretion by 3T3-L1 adipocytes: evidence for a skeletal muscle-to-fat signaling pathway. Cell Biol Int. (2005 ) 29:449–57.

    Not in our library10.1016/j.cellbi.2005.02.005

  184. 184.

    Longo VD Panda S. Fasting, circadian rhythms, and time-restricted feeding in healthy lifespan. Cell Metab. (2016 ) 23:1048–59.

    Not in our library10.1016/j.cmet.2016.06.001

  185. 185.

    Bass J Lazar MA. Circadian time signatures of fitness and disease. Science (2016 ) 354:994–9.

    Not in our library10.1126/science.aah4965

  186. 186.

    Bedrosian TA Fonken LK Nelson RJ. Endocrine effects of circadian disruption. Annu Rev Physiol. (2016 ) 78:109–31.

    Not in our library10.1146/annurev-physiol-021115-105102

  187. 187.

    McClung CA. Circadian genes, rhythms and the biology of mood disorders. Pharmacol Ther. (2007 ) 114:222–32.

    Not in our library10.1016/j.pharmthera.2007.02.003

  188. 188.

    Wulff K Gatti S Wettstein JG Foster RG. Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nat Rev Neurosci. (2010 ) 11:589–99.

    Not in our library10.1038/nrn2868

  189. 189.

    Andrews JL Zhang X McCarthy JJ McDearmon EL Hornberger TA Russell B. CLOCK and BMAL1 regulate MyoD and are necessary for maintenance of skeletal muscle phenotype and function. Proc Natl Acad Sci USA. (2010 ) 107:19090–5.

    Not in our library10.1073/pnas.1014523107

  190. 190.

    Loizides-Mangold U Perrin L Vandereycken B Betts JA Walhin J-P Templeman I. Lipidomics reveals diurnal lipid oscillations in human skeletal muscle persisting in cellular myotubes cultured in vitro. Proc Natl Acad Sci USA. (2017 ) 114:E8565–74.

    Not in our library10.1073/pnas.1705821114

  191. 191.

    Woldt E Sebti Y Solt LA Duhem C Lancel S Eeckhoute J. Rev-erb-α modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy. Nat Med. (2013 ) 19:1039–46.

    Not in our library10.1038/nm.3213

  192. 192.

    Aoyama S Shibata S. The role of circadian rhythms in muscular and osseous physiology and their regulation by nutrition and exercise. Front Neurosci. (2017 ) 11:63.

    Not in our library10.3389/fnins.2017.00063

  193. 193.

    Wolff G Esser KA. Scheduled exercise phase shifts the circadian clock in skeletal muscle. Med Sci Sports Exerc. (2012 ) 44:1663–70.

    Not in our library10.1249/mss.0b013e318255cf4c

  194. 194.

    Perrin L Loizides-Mangold U Skarupelova S Pulimeno P Chanon S Robert M. Human skeletal myotubes display a cell-autonomous circadian clock implicated in basal myokine secretion. Mol Metab. (2015 ) 4:834–45.

    Not in our library10.1016/j.molmet.2015.07.009

  195. 195.

    Liu C Li S Liu T Borjigin J Lin JD. Transcriptional coactivator PGC-1α integrates the mammalian clock and energy metabolism. Nature (2007 ) 447:477–81.

    Not in our library10.1038/nature05767

  196. 196.

    Eckel-Mahan K Sassone-Corsi P. Metabolism and the circadian clock converge. Physiol Rev. (2013 ) 93:107–35.

    Not in our library10.1152/physrev.00016.2012

  197. 197.

    Gerstner JR Lyons LC Wright KP Loh DH Rawashdeh O Eckel-Mahan KL. Cycling behavior and memory formation. J Neurosci. (2009 ) 29:12824–30.

    Not in our library10.1523/jneurosci.3353-09.2009

  198. 198.

    Jilg A Lesny S Peruzki N Schwegler H Selbach O Dehghani F. Temporal dynamics of mouse hippocampal clock gene expression support memory processing. Hippocampus (2010 ) 20:377–88.

    Not in our library10.1002/hipo.20637

  199. 199.

    Marpegan L Swanstrom AE Chung K Simon T Haydon PG Khan SK. Circadian regulation of ATP release in astrocytes. J Neurosci.(2011 ) 31:8342–50.

    Not in our library10.1523/jneurosci.6537-10.2011

  200. 200.

    Musiek ES Lim MM Yang G Bauer AQ Qi L Lee Y. Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration. J Clin Invest. (2013 ) 123:5389–400.

    Not in our library10.1172/jci70317

  201. 201.

    Valnegri P Khelfaoui M Dorseuil O Bassani S Lagneaux C Gianfelice A. A circadian clock in hippocampus is regulated by interaction between oligophrenin-1 and Rev-erbalpha. Nat Neurosci. (2011 ) 14:1293–301.

    Not in our library10.1038/nn.2911

  202. 202.

    Catoire M Kersten S. The search for exercise factors in humans. FASEB J. (2015 ) 29:1615–28.

    Not in our library10.1096/fj.14-263699

Cited by papers we hold 9

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.